logo
  

Pre-market Movers: BON, FB, BPTS, LSPD, SNAP…

us pre market 053119 03feb22 lt

The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).

In the Green

Bon Natural Life Limited (BON) is up over 36% at $4.61
Biophytis SA (BPTS) is up over 19% at $5.55
KLX Energy Services Holdings, Inc. (KLXE) is up over 10% at $6
NRx Pharmaceuticals, Inc. (NRXP) is up over 10% at $3.24
Better Therapeutics, Inc. (BTTX) is up over 9% at $3.90
Syros Pharmaceuticals, Inc. (SYRS) is up over 6% at $2.06
Flex Ltd. (FLEX) is up over 5% at $17.75
Alignment Healthcare, Inc. (ALHC) is up over 5% at $8.20
HeartBeam, Inc. (BEAT) is up over 5% at $2.16

In the Red

Meta Platforms, Inc. (FB) is down over 21% at $251.96
Lightspeed Commerce Inc. (LSPD) is down over 17% at $26.51
Snap Inc. (SNAP) is down over 15% at $27.12
GWG Holdings, Inc. (GWGH) is down over 13% at $3.88
Spotify Technology S.A. (SPOT) is down over 9% at $173.50
NETGEAR, Inc. (NTGR) is down over 9% at $25.62

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amazon has unveiled millions of deals worldwide that will be available during its upcoming Prime Day extravaganza. The 48-hour shopping event for Prime members kicks off July 12 at 3 a.m. EDT, offering deals of up to 79% off across various categories. These include electronics, devices, toys, beauty, fashion, and home, from top national brands and small businesses. Primal Pet Foods is recalling a single lot of Raw Frozen Primal Patties for Dogs Beef Formula due to potential contamination with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves lot #W10068709 of 6-pound Raw Frozen Primal Patties with best by date of 05/22/23. The Raw Frozen Primal Patties are sold in flexible packaging in the freezer at select pet stores. The U.S. Food and Drug Administration has authorized state-licensed pharmacists to prescribe COVID-19 pill Paxlovid (nirmatrelvir and ritonavir) by drug major Pfizer Inc. to eligible patients, with certain limitations. The agency has revised the Emergency Use Authorization or EUA for Paxlovid for the authorization, which could improve access for some patients at high risk for severe covid-19.
Follow RTT